Intravenous administration of glial cell line‐derived neurotrophic factor gene‐modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Neuroscience Research

• Publication date

  2006-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jnr.21056PMID 16998918PMCID PMC2605367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.

  2006cited by this paper
• Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model.

  2005cited by this paper
• I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.

  2005cited by this paper
• BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model.

  2004cited by this paper
• A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats.

  2004cited by this paper
• Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector.

  2003cited by this paper
• Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells.

  2003cited by this paper
• Therapeutic time window of adenovirus-mediated GDNF gene transfer after transient middle cerebral artery occlusion in rat.

  2002influential reference
• Ischemic rat brain extracts induce human marrow stromal cell growth factor production

  2002cited by this paper
• Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF‐producing cells in a rat model of Parkinson's disease

  2002cited by this paper
• Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice.

  2001cited by this paper
• Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats.

  2001cited by this paper
• Time dependent amelioration against ischemic brain damage by glial cell line-derived neurotrophic factor after transient middle cerebral artery occlusion in rat.

  2001cited by this paper
• Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation.

  2000influential reference
• CTLA4IgG gene delivery prevents autoantibody production and lupus nephritis in MRL/lpr mice.

  2000cited by this paper
• Angiogenesis Induced by the Implantation of Self-Bone Marrow Cells: A New Material for Therapeutic Angiogenesis

  2000cited by this paper
• Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats.

  1998cited by this paper
• Phenotypic and functional comparison of cultures of marrow‐derived mesenchymal stem cells (MSCs) and stromal cells

  1998cited by this paper
• Persistent and Secondary Adenovirus-Mediated Hepatic Gene Expression Using Adenovirus Vector Containing CTLA4IgG

  1998cited by this paper
• Expression of the glial cell line-derived neurotrophic factor gene in rat brain after transient MCA occlusion.

  1997influential reference
• Expression of glial cell line-derived neurotrophic factor (GDNF) mRNA following mechanical injury to mouse striatum.

  1997cited by this paper
• Glial Cell Line-Derived Neurotrophic Factor Protects against Ischemia-Induced Injury in the Cerebral Cortex

  1997cited by this paper
• Sensitivity and reproducibility in adenoviral infectious titer determination

  1997influential reference
• In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons

  1995cited by this paper
• Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor.

  1995cited by this paper
• Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

  1995cited by this paper
• Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

  1995cited by this paper
• Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF

  1995cited by this paper
• GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle.

  1994cited by this paper
• Adoptive immunotherapy with murine tumor-specific T lymphocytes engineered to secrete interleukin 2.

  1994cited by this paper
• GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.

  1993cited by this paper
• Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer.

  1991cited by this paper
• Reversible middle cerebral artery occlusion without craniectomy in rats.

  1989cited by this paper
• Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.

  1986cited by this paper
• Biochemical-physiology correlations in studies of the γ-aminobutyric acid system

  1968cited by this paper

• Mesenchymal stem cells and the central nervous system: historical perspectives and future directions

  2026cites this paper
• Therapeutic role of mesenchymal stem cells in neurogenesis for management of neurological disorders: a scientometric study to an in-depth review

  2025cites this paper
• The promise of stem cell therapies for cellular recovery after stroke

  2025cites this paper
• Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies

  2025cites this paper
• Unveiling synergies: Integrating TCM herbal medicine and acupuncture with conventional approaches in stroke management.

  2024cites this paper
• Stem Cell Therapy and Thiamine Deficiency-Induced Brain Damage

  2024cites this paper
• The Secretome of Mesenchymal Stromal Cells as a New Hope in the Treatment of Acute Brain Tissue Injuries

  2024cites this paper
• Corticospinal tract: a new hope for the treatment of post-stroke spasticity

  2023cites this paper
• Intravenous human dental pulp-derived mesenchymal stem cell therapy for ischemic stroke in rats: an analysis of functional and ischemic brain areas outcomes

  2023cites this paper
• iPSC-derived mesenchymal stem cells attenuate cerebral ischemia-reperfusion injury by inhibiting inflammatory signaling and oxidative stress

  2023cites this paper
• Hippocampal region-specific endogenous neuroprotection as an approach in the search for new neuroprotective strategies in ischemic stroke. Fiction or fact?

  2022cites this paper
• Dose-Dependent Effects of Intravenous Mesenchymal Stem Cell Transplantation in Rats with Acute Focal Cerebral Ischemia

  2022cites this paper
• Extended Ischemic Recovery After Implantation of Human Mesenchymal Stem Cell Aggregates Indicated by Sodium MRI at 21.1 T

  2022cites this paper
• The impacts of anesthetic regimens on the middle cerebral artery occlusion outcomes in male rats

  2022cites this paper
• Preconditioning with secretome of neural crest-derived stem cells enhanced neurotrophic expression in mesenchymal stem cells.

  2022cites this paper
• Treatment of ischemic stroke with modified mesenchymal stem cells

  2022cites this paper
• Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease

  2022cites this paper
• Mesenchymal Stem Cells for Neurological Disorders

  2021cites this paper
• Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases

  2021cites this paper
• Rodent Stroke Model Guidelines: An Update

  2021cites this paper
• Current status of ischemic stroke treatment: From thrombolysis to potential regenerative medicine

  2021influential citation
• Effects of platelet‐rich plasma on the memory impairment, apoptosis, and hippocampal synaptic plasticity in a rat model of hepatic encephalopathy

  2021cites this paper
• Glial Cell Line-Derived Neurotrophic Factor and Focal Ischemic Stroke

  2021cites this paper
• Strategies to Improve the Quality and Freshness of Human Bone Marrow-Derived Mesenchymal Stem Cells for Neurological Diseases

  2021cites this paper
• Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke

  2021influential citation
• NODDI highlights recovery mechanisms in white and gray matter in ischemic stroke following human stem cell treatment

  2021cites this paper
• Researches and Applications of Stem Cell Secretome

  2021cites this paper
• Beyond the Hippocampus and the SVZ: Adult Neurogenesis Throughout the Brain

  2020cites this paper
• Harnessing the anti-inflammatory properties of stem cells for transplant therapy in hemorrhagic stroke

  2020cites this paper
• Mesenchymal stem cell therapy alleviates the neuroinflammation associated with acquired brain injury

  2020cites this paper
• Glial cell induced neural differentiation of bone marrow stromal cells

  2020cites this paper
• GLAST‐CreERT2 mediated deletion of GDNF increases brain damage and exacerbates long‐term stroke outcomes after focal ischemic stroke in mouse model

  2020cites this paper
• Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke

  2020cites this paper
• The Beneficial Potential of Genetically Modified Stem Cells in the Treatment of Stroke: a Review

  2020cites this paper
• Early Transplantation of Human Cranial Bone-derived Mesenchymal Stem Cells Enhances Functional Recovery in Ischemic Stroke Model Rats

  2020cites this paper
• Efficacy of Stem Cell-Based Therapies for Stroke.

  2019cites this paper
• Therapeutic effect on experimental acute cerebral infarction is enhanced after nanoceria labeling of human umbilical cord mesenchymal stem cells

  2019cites this paper
• Protective Role of SOCS3 Modified Bone Marrow Mesenchymal Stem Cells in Hypoxia-Induced Injury of PC12 Cells

  2019cites this paper
• Biological functions of mesenchymal stem cells and clinical implications

  2019cites this paper
• Investigation of Neuregulin-1 and Glial Cell-Derived Neurotrophic Factor in Rodent Astrocytes and Microglia

  2019cites this paper
• Effects of GDNF-Transfected Marrow Stromal Cells on Rats with Intracerebral Hemorrhage.

  2019cites this paper
• Protective effects of mesenchymal stem cells overexpressing extracellular regulating kinase 1/2 against stroke in rats.

  2019cites this paper
• Inflammation and neural repair after ischemic brain injury.

  2019cites this paper
• Enhancement of the efficacy of mesenchymal stem cells in the treatment of ischemic diseases.

  2019cites this paper
• Advanced nanotherapies to promote neuroregeneration in the injured newborn brain.

  2019cites this paper
• NRG1–ErbB4 signaling promotes functional recovery in a murine model of traumatic brain injury via regulation of GABA release

  2019cites this paper
• Intravenous infusion of mesenchymal stem cells promotes functional recovery in a rat model of chronic cerebral infarction.

  2019cites this paper
• Promoting Brain Repair and Regeneration After Stroke: a Plea for Cell-Based Therapies

  2019cites this paper
• Stem Cell Therapy for Ischemic Stroke: From Bench to Bedside

  2018cites this paper
• [8. Evaluation of the Therapeutic Mechanisms in Regeneration Therapy for Cerebral Infarction Using Pre-clinical Magnetic Resonance Imaging].

  2018cites this paper
• Reactive Astrocytes in Cerebral Ischemic Reperfusion Injury

  2018cites this paper
• Comparison between the effect of human Wharton’s jelly–derived mesenchymal stem cells and levetiracetam on brain infarcts in rats

  2018cites this paper
• Adult Stem Cell-Based Strategies for Peripheral Nerve Regeneration.

  2018cites this paper
• Cerebral Ischemic Reperfusion Injuries (CIRI)

  2018influential citation
• Exercise as a Positive Modulator of Brain Function

  2018cites this paper
• The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke

  2018cites this paper
• Effects of labeling human mesenchymal stem cells with superparamagnetic iron oxides on cellular functions and magnetic resonance contrast in hypoxic environments and long-term monitoring

  2018cites this paper
• Treatments to Promote Neural Repair after Stroke

  2018cites this paper
• Potential for stem cell treatment in manganism.

  2018cites this paper
• Multicentre evaluation of MRI variability in the quantification of infarct size in experimental focal cerebral ischaemia

  2017cites this paper
• Therapeutic effect by combining rehabilitation and intravenous infusion of mesenchymal stem cells after experimental stroke in rats

  2017cites this paper
• Effect of Single and Double Administration of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Following Focal Cerebral Ischemia in Rats

  2017cites this paper
• Collagen and Elastin Biomaterials for the Fabrication of Engineered Living Tissues.

  2017cites this paper
• Fibroblast Growth Factor 1-Transfected Adipose-Derived Mesenchymal Stem Cells Promote Angiogenic Proliferation

  2017cites this paper
• Ex vivo gene therapy for the treatment of neurological disorders.

  2017cites this paper
• Effect of Adipose-Derived Mesenchymal Stem Cell Administration and Mild Hypothermia Induction on Delayed Neuronal Death After Transient Global Cerebral Ischemia

  2017cites this paper
• Fibroblast Growth Factor Type 1 (FGF1)-Overexpressed Adipose-Derived Mesenchaymal Stem Cells (AD-MSCFGF1) Induce Neuroprotection and Functional Recovery in a Rat Stroke Model

  2017cites this paper
• Mesenchymal Stem Cells

  2017cites this paper
• Stem cell therapy for abrogating stroke‐induced neuroinflammation and relevant secondary cell death mechanisms

  2017cites this paper
• Stem Cell Research for the Treatment of Malignant Glioma

  2017cites this paper
• Increased Susceptibility to Ischemic Brain Injury in Neuroplastin 65-Deficient Mice Likely via Glutamate Excitotoxicity

  2017cites this paper
• The preferential homing of mesenchymal stromal cells to sites of inflammation

  2016cites this paper
• Tracking mesenchymal stem cells using magnetic resonance imaging

  2016cites this paper
• The potential role of bone marrow mesenchymal stromal cells in the treatment of ischemic stroke

  2016cites this paper
• Cell based therapeutics for retinal degenerations

  2016influential citation
• Reactive gliosis in the pathogenesis of CNS diseases.

  2016cites this paper
• Mesenchymal stromal cell therapy in ischemic stroke

  2016cites this paper
• Current developments in cell- and biomaterial-based approaches for stroke repair

  2016cites this paper
• 31 – Imaging and Adenoviral Gene Therapy

  2016cites this paper
• Neural Stem Cells-interaction with the brain and prospects for cell replacement therapy for Stroke

  2016cites this paper
• Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies

  2016cites this paper
• Hypoxic and ischemic effects on gene and protein expression levels of paracrine factors by human olfactory mucosa mesenchymal-like stem cells

  2016cites this paper
• Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair.

  2016cites this paper
• Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies

  2015cites this paper
• CdSe/ZnS Quantum Dots-Labeled Mesenchymal Stem Cells for Targeted Fluorescence Imaging of Pancreas Tissues and Therapy of Type 1 Diabetic Rats

  2015cites this paper
• Neural Stem Cells - interaction with the brain and prospects for cell replacement therapy for Stroke

  2015cites this paper
• Multitheragnostic Multi‐GNRs Crystal‐Seeded Magnetic Nanoseaurchin for Enhanced In Vivo Mesenchymal‐Stem‐Cell Homing, Multimodal Imaging, and Stroke Therapy

  2015cites this paper
• Mechanisms and Functional Significance of Stroke-Induced Neurogenesis

  2015cites this paper
• Magnetic Resonance Imaging in Experimental Stroke and Comparison With Histology: Systematic Review and Meta-Analysis

  2015cites this paper
• Cell Therapy for Traumatic Brain Injury: Opportunities and Pitfalls

  2015cites this paper
• TiO2-Nanowired Delivery of Mesenchymal Stem Cells Thwarts Diabetes- Induced Exacerbation of Brain Pathology in Heat Stroke: An Experimental Study in the Rat Using Morphological and Biochemical Approaches.

  2015cites this paper
• Bone-marrow-derived mesenchymal stem cells attenuate cognitive deficits in an endothelin-1 rat model of stroke

  2015cites this paper
• Bone-marrow-derived mesenchymal stem cells attenuate cognitive deficits in an endothelin-1 rat model of stroke.

  2015cites this paper
• Mesenchymal autologous stem cells.

  2015cites this paper
• Priming Wharton's Jelly‐Derived Mesenchymal Stromal/Stem Cells With ROCK Inhibitor Improves Recovery in an Intracerebral Hemorrhage Model

  2015cites this paper
• [Treatment of cerebral ischemia using mesenchymal stem cell-clinical trial phase III].

  2015cites this paper
• Effect of adipose derived mesenchymal stem cells administration and therapeutic induction of hypothermia on delayed neuronal death after transient global cerebral ischemia

  2014cites this paper
• Astrocyte reactivity and reactive astrogliosis: costs and benefits.

  2014cites this paper
• Stem Cell-Based Therapies for Ischemic Stroke

  2014cites this paper
• Bone marrow stromal cells as a therapeutic treatment for ischemic stroke

  2014cites this paper